An Interview With Theresa Neil, Founder And CEO At Guidea

SSupported by cloud service provider DigitalOcean – Try DigitalOcean now and receive a $200 when you create a new account!
Listen to this article

Below is our recent interview with Theresa Neil, the Founder and CEO at Guidea:

Q: What is Guidea?

A: Guidea is a women-owned, women-led UX consultancy with extensive product and design strategy expertise in HealthTech and MedTech. The team is a trusted partner to 20 Fortune 100 companies and has launched almost 300 products and services to date. Since 2005, Guidea has invested in 70+ startups that now have a combined valuation of $20B. Their partnerships with some of the world’s most innovative companies have earned awards like: The MedTech Breakthrough Award, Most Innovative Digital Health Solutions Platform, and Best SaaS-Enabled Digital Health Platform.

Recommended: Matter Will Revolutionize Smart Connectivity In Our Homes, Cities And Beyond

Q: Can you give us more insights into your offering?

A: Guidea’s Femovate program offers FemTech (female centric health tech) startups UX research, design, and mentorship services at little to no cost. Guidea Founder and CEO Theresa Neil, created the program to help FemTech founders quickly create and/or refine their products to provide a better experience for users and improve traction with investors.

Q: What can we expect from your company in next 6 months? What are your plans?

A: Guidea is currently providing UX research, strategy and product design for 30 FemTech companies across 15 verticals. Over the next six months, Guidea will share the stories of each startup and how UX design has helped each team attract and retain customers while improving traction with investors.

Recommended: Orcoda (ASX:ODA) Goes From Peak To Peak In Streamlining Snowfield Transport And Logistics

Q: What is the best thing about your company that people might not know about?

A: Guidea’s deep MedTech expertise stems from hiring and retaining senior practitioners. Experts stay at Guidea, on average, 8 years, 4 x longer than the average agency tenure.